<table id="id_4927a80e-19ff-4545-9526-1a155e8e10ec" width="0.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_cbb9e7fa-10b9-49f7-9bbc-8bda1a8972b0">Table 1: RELATIVE AND ABSOLUTE RISK SEEN IN THE CE/MPA SUBSTUDY OF WHI<footnote id="id-e0da4c8d-d931-4e2d-ad26-35eca3e4eb02">adapted from JAMA, 2002; 288:321-333<br/>
</footnote>
</caption>
<col></col>
<col></col>
<col></col>
<col></col>
<tbody>
<tr id="id_18162498-1efb-496d-86e5-b4b2eddc5324" stylecode="Toprule">
<td align="left" valign="top">Event <footnote id="id-be0a2794-92fa-4bf3-b31e-09a7c62787be">a subset of the events was combined in a “global index”, defined as the earliest occurrence of CHD events, invasive breast cancer, stroke, pulmonary embolism, endometrial cancer, colorectal cancer, hip fracture, or death due to other causes<br/>
</footnote>
</td>
<td align="left" stylecode="Toprule" valign="top">
<paragraph>Relative Risk <br/>CE/MPA vs placebo<br/> at 5.2 Years</paragraph>(95% CI<footnote id="id-cf24008a-8843-4250-b44b-2f0349063b65">nominal confidence intervals unadjusted for multiple looks and multiple comparisons</footnote>)</td>
<td align="left" stylecode="Toprule" valign="top">Placebo<br/>n = 8102</td>
<td align="left" valign="top">
<paragraph>CE/MPA</paragraph>n = 8506</td>
</tr>
<tr id="id_55a240a7-5953-4c4a-9ad4-13b6e356b6ae">
<td align="left" valign="top"></td>
<td align="left" valign="top"></td>
<td align="left" colspan="2" valign="top">
<paragraph>Absolute Risk per 10,000 Women-years</paragraph>
</td>
</tr>
<tr id="id_3abadc82-a557-4ec2-81f8-b0260c572e96">
<td align="left" valign="top">CHD events<br/>
<content stylecode="italics">Non-fatal MI<br/> CHD death</content>
</td>
<td align="center" valign="middle">1.29 (1.02 to 1.63)<br/>
<content stylecode="italics">1.32 (1.02 to 1.72)<br/>1.18 (0.70 to 1.97)</content>
</td>
<td align="center" valign="middle">30<br/>23<br/>6</td>
<td align="center" valign="middle">37<br/>
<content stylecode="italics">30<br/>7</content>
</td>
</tr>
<tr id="id_f8e793cb-9872-4edc-aa18-e17415214e42">
<td align="left" valign="top">Invasive breast cancer<footnote id="id-4d51985e-b275-4098-b608-6ff4e5216b88">includes metastatic and non-metastatic breast cancer with the exception of in situ breast cancer<br/>
</footnote>
</td>
<td align="center" valign="middle">1.26 (1.00 to 1.59)</td>
<td align="center" valign="middle">30</td>
<td align="center" valign="middle">38</td>
</tr>
<tr id="id_f9cda64b-1c0f-4518-b912-d0786d048cc9">
<td align="left" valign="top">Stroke</td>
<td align="center" valign="middle">1.41 (1.07 to 1.85)</td>
<td align="center" valign="middle">21</td>
<td align="center" valign="middle">29</td>
</tr>
<tr id="id_c63d18dc-6bd1-441e-96e4-685f0c85d95e">
<td align="left" valign="top">Pulmonary embolism</td>
<td align="center" valign="middle">2.13 (1.39 to 3.25)</td>
<td align="center" valign="middle">8</td>
<td align="center" valign="middle">16</td>
</tr>
<tr id="id_79372db3-4697-4e99-8452-2ba130f874eb">
<td align="left" valign="top">Colorectal cancer</td>
<td align="center" valign="middle">0.63 (0.43 to 0.92)</td>
<td align="center" valign="middle">16</td>
<td align="center" valign="middle">10</td>
</tr>
<tr id="id_bb67634f-f5a7-405d-833f-5898de9a9717">
<td align="left" valign="top">Endometrial cancer</td>
<td align="center" valign="middle">0.83 (0.47 to 1.47)</td>
<td align="center" valign="middle">6</td>
<td align="center" valign="middle">5</td>
</tr>
<tr id="id_719a5cd7-2624-476a-93b5-c6682642a329">
<td align="left" valign="top">Hip fracture</td>
<td align="center" valign="middle">0.66 (0.45 to 0.98)</td>
<td align="center" valign="middle">15</td>
<td align="center" valign="middle">10</td>
</tr>
<tr id="id_18c716c3-163d-4c83-8977-94c9434c72cc">
<td align="left" valign="top">Death due to causes other than the events above</td>
<td align="center" valign="middle">0.92 (0.74 to 1.14)</td>
<td align="center" valign="middle">40</td>
<td align="center" valign="middle">37</td>
</tr>
<tr id="id_f3984db3-b8c7-47fe-b144-e0a17896a551">
<td align="left" valign="top">Global Index<footnoteref idref="id-be0a2794-92fa-4bf3-b31e-09a7c62787be"></footnoteref>
</td>
<td align="center" valign="middle">1.15 (1.03 to 1.28)</td>
<td align="center" valign="middle">151</td>
<td align="center" valign="middle">170</td>
</tr>
<tr id="id_a2a67651-9e55-4a21-aaaf-f3f1385a6a67">
<td align="left" valign="top">Deep vein thrombosis<footnote id="id-f14e9321-a581-482b-809d-cce24853af3c">not included in Global Index<br/>
</footnote>
</td>
<td align="center" valign="middle">2.07 (1.49 to 2.87)</td>
<td align="center" valign="middle">13</td>
<td align="center" valign="middle">26</td>
</tr>
<tr id="id_6ce41ac7-832b-4973-81de-7280e3bf5957">
<td align="left" valign="top">Vertebral fractures<footnoteref idref="id-f14e9321-a581-482b-809d-cce24853af3c"></footnoteref>
</td>
<td align="center" valign="middle">0.66 (0.44 to 0.98)</td>
<td align="center" valign="middle">15</td>
<td align="center" valign="middle">9</td>
</tr>
<tr id="id_c30f9e5a-691f-4aa7-b7a6-37ae91a6a0bf" stylecode="Botrule">
<td align="left" valign="top">Other osteoporotic fractures<footnoteref idref="id-f14e9321-a581-482b-809d-cce24853af3c"></footnoteref>
</td>
<td align="center" valign="middle">0.77 (0.69 to 0.86)</td>
<td align="center" valign="middle">170</td>
<td align="center" valign="middle">131</td>
</tr>
</tbody>
</table>